Immuron (IMRN) Change in Accured Expenses (2022)

Immuron (IMRN) posted quarterly Change in Accured Expenses of $204577.7 for Q2 2022.

Immuron (IMRN) Change in Accured Expenses (2022) Analysis & Trends

Immuron's Change in Accured Expenses history runs 1 years deep, the most recent figure standing at $204577.7 for Q2 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Accured Expenses (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	222.50 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	492.70 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	11.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	212.44 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	61.62 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	68.82 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Immuron	6.75 Mn	6.73 Mn	-	-

Download Data

Date	Value
Jun 30, 2022	204,577.69
Jun 30, 2022	204,577.69